English

Midatech Pharma Plc

EDGAR

BDRX Report (type unavailable) · filed 2026-10-08

293 filing records in this dataset, filed from 2015-08-11 to 2026-10-08. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

381 thousand GBP

2023 · GBP

Exact inputs and evidence

Revenue: 381000 GBP Source

Operating margin

-2,103.41%

2023 · %

Exact inputs and evidence

Operating Income: -8014000 GBP Source
Revenue: 381000 GBP Source

Operating cash flow

-6.83 million GBP

2023 · GBP

Exact inputs and evidence

Operating Cash Flow: -6826000 GBP Source

Free cash flow

-6.85 million GBP

2023 · GBP

Exact inputs and evidence

Operating Cash Flow: -6826000 GBP Source
Capital Expenditure: 26000 GBP Source

Cash and cash equivalents: 8.53 million GBP 2025-12-31 Source
Exact value

8534000 GBP
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-08.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2023-12-31
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 3 of 11 periods available· newest 2023-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 9 of 11 periods available· newest 2025-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 9 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Operating cash flow
+GBP 6.67 million

Prior period

−GBP 12.26 million

2024-01-01 – 2024-12-31
Current period

−GBP 5.59 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-5591000 − -12261000 = 6670000 GBP

-12261000 GBP · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-5591000 GBP · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Midatech Pharma Plc · 2025-12-31 Midatech Pharma Plc (edgar:1643918) Year-over-year change in Operating cash flow: 6670000 GBP Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -5591000 GBP (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1946861 Filing: 000121465926003921 Input fundies:OperatingCashFlow: -12261000 GBP (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1947491 Filing: 000121465926003921
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-77.8%

Prior period

GBP 9,000

2024-01-01 – 2024-12-31
Current period

GBP 2,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

2000 − 9000 = -7000 GBP

9000 GBP · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
2000 GBP · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Midatech Pharma Plc · 2025-12-31 Midatech Pharma Plc (edgar:1643918) Year-over-year change in Capital expenditure: -7000 GBP Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2000 GBP (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1953473 Filing: 000121465926003921 Input fundies:CapitalExpenditure: 9000 GBP (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1953959 Filing: 000121465926003921
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue GBP 381,000 100% of revenue
Operating costs Derived GBP 8.4 million 2,203% of revenue
Operating income −GBP 8.01 million −2,103% of revenue
Tax, interest and other Derived −GBP 935,000 −245% of revenue
Net income −GBP 7.08 million −1,858% of revenue

Cash

Operating cash flow −GBP 6.83 million −1,792% of revenue
Capital expenditure GBP 26,000 6.8% of revenue
Free cash flow Derived −GBP 6.85 million −1,798% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.
2021 Operating loss: operating costs were 1,311% of revenue.
2022 Operating loss: operating costs were 1,378% of revenue.
2023 Operating loss: operating costs were 2,203% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	989000	14265000 Derived	-13276000	Unavailable	Unavailable	-13660000 Derived	Source 2017-01-01 – 2017-12-31: 989000 GBP Inspect Revenue Open source 2017-01-01 – 2017-12-31: -13276000 GBP Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -12953000 GBP Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 707000 GBP Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	1938000	13753000 Derived	-11815000	Unavailable	Unavailable	-13694000 Derived	Source 2018-01-01 – 2018-12-31: 1938000 GBP Inspect Revenue Open source 2018-01-01 – 2018-12-31: -11815000 GBP Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -13450000 GBP Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 244000 GBP Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	674000	11992000 Derived	-11318000	Unavailable	Unavailable	-6799000 Derived	Source 2019-01-01 – 2019-12-31: 674000 GBP Inspect Revenue Open source 2019-01-01 – 2019-12-31: -11318000 GBP Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -6489000 GBP Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 310000 GBP Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	343000	23383000 Derived	-23040000	Unavailable	Unavailable	-9510000 Derived	Source 2020-01-01 – 2020-12-31: 343000 GBP Inspect Revenue Open source 2020-01-01 – 2020-12-31: -23040000 GBP Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -9301000 GBP Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 209000 GBP Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	578000	7576000 Derived	-6998000	-1538000 Derived	-5460000	-6328000 Derived	Source 2021-01-01 – 2021-12-31: 578000 GBP Inspect Revenue Open source 2021-01-01 – 2021-12-31: -6998000 GBP Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -5460000 GBP Inspect Net Income Open source 2021-01-01 – 2021-12-31: -6008000 GBP Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 320000 GBP Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	699000	9631000 Derived	-8932000	-1276000 Derived	-7656000	-7110000 Derived	Source 2022-01-01 – 2022-12-31: 699000 GBP Inspect Revenue Open source 2022-01-01 – 2022-12-31: -8932000 GBP Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -7656000 GBP Inspect Net Income Open source 2022-01-01 – 2022-12-31: -7048000 GBP Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 62000 GBP Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	381000	8395000 Derived	-8014000	-935000 Derived	-7079000	-6852000 Derived	Source 2023-01-01 – 2023-12-31: 381000 GBP Inspect Revenue Open source 2023-01-01 – 2023-12-31: -8014000 GBP Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -7079000 GBP Inspect Net Income Open source 2023-01-01 – 2023-12-31: -6826000 GBP Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 26000 GBP Inspect Capital Expenditure Open source

Amounts are exact, in GBP.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

GBP 381K 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(GBP)	Source evidence
20172017-12-31	Revenue	989000	Revenue: 989000 Open source
20182018-12-31	Revenue	1938000	Revenue: 1938000 Open source
20192019-12-31	Revenue	674000	Revenue: 674000 Open source
20202020-12-31	Revenue	343000	Revenue: 343000 Open source
20212021-12-31	Revenue	578000	Revenue: 578000 Open source
20222022-12-31	Revenue	699000	Revenue: 699000 Open source
20232023-12-31	Revenue	381000	Revenue: 381000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-45.5% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 989000 Open source
20182018-12-31	Year over year	96%	Revenue: 1938000 Open source Revenue: 989000 Open source
20192019-12-31	Year over year	-65.2%	Revenue: 674000 Open source Revenue: 1938000 Open source
20202020-12-31	Year over year	-49.1%	Revenue: 343000 Open source Revenue: 674000 Open source
20212021-12-31	Year over year	68.5%	Revenue: 578000 Open source Revenue: 343000 Open source
20222022-12-31	Year over year	20.9%	Revenue: 699000 Open source Revenue: 578000 Open source
20232023-12-31	Year over year	-45.5%	Revenue: 381000 Open source Revenue: 699000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2,103.4% 2023

Net margin -1,858% 2023

Free cash flow margin -1,798.4% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-1,342.4%	Operating Income: -13276000 Open source Revenue: 989000 Open source
20182018-12-31	Operating margin	-609.6%	Operating Income: -11815000 Open source Revenue: 1938000 Open source
20192019-12-31	Operating margin	-1,679.2%	Operating Income: -11318000 Open source Revenue: 674000 Open source
20202020-12-31	Operating margin	-6,717.2%	Operating Income: -23040000 Open source Revenue: 343000 Open source
20212021-12-31	Operating margin	-1,210.7%	Operating Income: -6998000 Open source Revenue: 578000 Open source
20222022-12-31	Operating margin	-1,277.8%	Operating Income: -8932000 Open source Revenue: 699000 Open source
20232023-12-31	Operating margin	-2,103.4%	Operating Income: -8014000 Open source Revenue: 381000 Open source
2017-12-31	Net margin	Not reported	Revenue: 989000 Open source
2018-12-31	Net margin	Not reported	Revenue: 1938000 Open source
2019-12-31	Net margin	Not reported	Revenue: 674000 Open source
2020-12-31	Net margin	Not reported	Revenue: 343000 Open source
20212021-12-31	Net margin	-944.6%	Net Income: -5460000 Open source Revenue: 578000 Open source
20222022-12-31	Net margin	-1,095.3%	Net Income: -7656000 Open source Revenue: 699000 Open source
20232023-12-31	Net margin	-1,858%	Net Income: -7079000 Open source Revenue: 381000 Open source
20172017-12-31	Free cash flow margin	-1,381.2%	Revenue: 989000 Open source Operating Cash Flow: -12953000 Open source Capital Expenditure: 707000 Open source
20182018-12-31	Free cash flow margin	-706.6%	Revenue: 1938000 Open source Operating Cash Flow: -13450000 Open source Capital Expenditure: 244000 Open source
20192019-12-31	Free cash flow margin	-1,008.8%	Revenue: 674000 Open source Operating Cash Flow: -6489000 Open source Capital Expenditure: 310000 Open source
20202020-12-31	Free cash flow margin	-2,772.6%	Revenue: 343000 Open source Operating Cash Flow: -9301000 Open source Capital Expenditure: 209000 Open source
20212021-12-31	Free cash flow margin	-1,094.8%	Revenue: 578000 Open source Operating Cash Flow: -6008000 Open source Capital Expenditure: 320000 Open source
20222022-12-31	Free cash flow margin	-1,017.2%	Revenue: 699000 Open source Operating Cash Flow: -7048000 Open source Capital Expenditure: 62000 Open source
20232023-12-31	Free cash flow margin	-1,798.4%	Revenue: 381000 Open source Operating Cash Flow: -6826000 Open source Capital Expenditure: 26000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

GBP -6.8M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(GBP)	Source evidence
20172017-12-31	Operating cash flow	-12953000	Operating Cash Flow: -12953000 Open source
20182018-12-31	Operating cash flow	-13450000	Operating Cash Flow: -13450000 Open source
20192019-12-31	Operating cash flow	-6489000	Operating Cash Flow: -6489000 Open source
20202020-12-31	Operating cash flow	-9301000	Operating Cash Flow: -9301000 Open source
20212021-12-31	Operating cash flow	-6008000	Operating Cash Flow: -6008000 Open source
20222022-12-31	Operating cash flow	-7048000	Operating Cash Flow: -7048000 Open source
20232023-12-31	Operating cash flow	-6826000	Operating Cash Flow: -6826000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

GBP -6.9M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(GBP)	Source evidence
20172017-12-31	Free cash flow	-13660000	Operating Cash Flow: -12953000 Open source Capital Expenditure: 707000 Open source
20182018-12-31	Free cash flow	-13694000	Operating Cash Flow: -13450000 Open source Capital Expenditure: 244000 Open source
20192019-12-31	Free cash flow	-6799000	Operating Cash Flow: -6489000 Open source Capital Expenditure: 310000 Open source
20202020-12-31	Free cash flow	-9510000	Operating Cash Flow: -9301000 Open source Capital Expenditure: 209000 Open source
20212021-12-31	Free cash flow	-6328000	Operating Cash Flow: -6008000 Open source Capital Expenditure: 320000 Open source
20222022-12-31	Free cash flow	-7110000	Operating Cash Flow: -7048000 Open source Capital Expenditure: 62000 Open source
20232023-12-31	Free cash flow	-6852000	Operating Cash Flow: -6826000 Open source Capital Expenditure: 26000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

55.6% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Liabilities / assets	29.6%	Total Liabilities: 14548000 Open source Total Assets: 49224000 Open source
20182018-12-31	Liabilities / assets	17.2%	Total Liabilities: 3520000 Open source Total Assets: 20444000 Open source
20192019-12-31	Liabilities / assets	36.7%	Total Liabilities: 11337000 Open source Total Assets: 30895000 Open source
20202020-12-31	Liabilities / assets	31.6%	Total Liabilities: 3099000 Open source Total Assets: 9817000 Open source
20212021-12-31	Liabilities / assets	19.1%	Total Liabilities: 2461000 Open source Total Assets: 12913000 Open source
20222022-12-31	Liabilities / assets	42.8%	Total Liabilities: 2363000 Open source Total Assets: 5525000 Open source
20232023-12-31	Liabilities / assets	55.6%	Total Liabilities: 5864000 Open source Total Assets: 10542000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.26× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	2.22×	Current Assets: 18583000 Open source Current Liabilities: 8363000 Open source
20182018-12-31	Current assets / current liabilities	2.27×	Current Assets: 5618000 Open source Current Liabilities: 2471000 Open source
20192019-12-31	Current assets / current liabilities	2.42×	Current Assets: 13737000 Open source Current Liabilities: 5667000 Open source
20202020-12-31	Current assets / current liabilities	3.1×	Current Assets: 9275000 Open source Current Liabilities: 2989000 Open source
20212021-12-31	Current assets / current liabilities	6.39×	Current Assets: 11761000 Open source Current Liabilities: 1841000 Open source
20222022-12-31	Current assets / current liabilities	2.47×	Current Assets: 4688000 Open source Current Liabilities: 1900000 Open source
20232023-12-31	Current assets / current liabilities	1.26×	Current Assets: 7030000 Open source Current Liabilities: 5569000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	Unavailable Not reported for this period.	−GBP 12.95 million Exact value Exact value: -12953000 GBP 2017-01-01 – 2017-12-31: -12953000 GBP Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Midatech Pharma Plc · 2017-12-31 Midatech Pharma Plc (edgar:1643918) Operating Cash Flow: -12953000 GBP Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=GBP&dimensions= Input fundies:OperatingCashFlow: -12953000 GBP (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465920005615/mtp-20191231.xml#3723747 Filing: 000121465920005615 The citation records this snapshot. The page link may show a newer release later.	GBP 707,000 Exact value Exact value: 707000 GBP 2017-01-01 – 2017-12-31: 707000 GBP Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Midatech Pharma Plc · 2017-12-31 Midatech Pharma Plc (edgar:1643918) Capital Expenditure: 707000 GBP Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=GBP&dimensions= Input fundies:CapitalExpenditure: 707000 GBP (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465920005615/mtp-20191231.xml#3930045 Filing: 000121465920005615 The citation records this snapshot. The page link may show a newer release later.	−GBP 13.66 million Calculation and evidence -12953000 − 707000 GBP Exact free cash flow: -13660000 GBP 2017-01-01 – 2017-12-31: -12953000 GBP · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 707000 GBP · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Midatech Pharma Plc · 2017-12-31 Midatech Pharma Plc (edgar:1643918) Free cash flow: -13660000 GBP Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12953000 GBP (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465920005615/mtp-20191231.xml#3723747 Filing: 000121465920005615 Input fundies:CapitalExpenditure: 707000 GBP (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465920005615/mtp-20191231.xml#3930045 Filing: 000121465920005615 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	Unavailable Not reported for this period.	−GBP 13.45 million Exact value Exact value: -13450000 GBP 2018-01-01 – 2018-12-31: -13450000 GBP Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Midatech Pharma Plc · 2018-12-31 Midatech Pharma Plc (edgar:1643918) Operating Cash Flow: -13450000 GBP Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=GBP&dimensions= Input fundies:OperatingCashFlow: -13450000 GBP (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465921004730/mtp-20201231.xml#519422 Filing: 000121465921004730 The citation records this snapshot. The page link may show a newer release later.	GBP 244,000 Exact value Exact value: 244000 GBP 2018-01-01 – 2018-12-31: 244000 GBP Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Midatech Pharma Plc · 2018-12-31 Midatech Pharma Plc (edgar:1643918) Capital Expenditure: 244000 GBP Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=GBP&dimensions= Input fundies:CapitalExpenditure: 244000 GBP (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465921004730/mtp-20201231.xml#530243 Filing: 000121465921004730 The citation records this snapshot. The page link may show a newer release later.	−GBP 13.69 million Calculation and evidence -13450000 − 244000 GBP Exact free cash flow: -13694000 GBP 2018-01-01 – 2018-12-31: -13450000 GBP · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 244000 GBP · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Midatech Pharma Plc · 2018-12-31 Midatech Pharma Plc (edgar:1643918) Free cash flow: -13694000 GBP Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13450000 GBP (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465921004730/mtp-20201231.xml#519422 Filing: 000121465921004730 Input fundies:CapitalExpenditure: 244000 GBP (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465921004730/mtp-20201231.xml#530243 Filing: 000121465921004730 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	Unavailable Not reported for this period.	−GBP 6.49 million Exact value Exact value: -6489000 GBP 2019-01-01 – 2019-12-31: -6489000 GBP Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Midatech Pharma Plc · 2019-12-31 Midatech Pharma Plc (edgar:1643918) Operating Cash Flow: -6489000 GBP Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=GBP&dimensions= Input fundies:OperatingCashFlow: -6489000 GBP (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465923003658/m31230f1.htm#2489682 Filing: 000121465923003658 The citation records this snapshot. The page link may show a newer release later.	GBP 310,000 Exact value Exact value: 310000 GBP 2019-01-01 – 2019-12-31: 310000 GBP Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Midatech Pharma Plc · 2019-12-31 Midatech Pharma Plc (edgar:1643918) Capital Expenditure: 310000 GBP Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=GBP&dimensions= Input fundies:CapitalExpenditure: 310000 GBP (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465923003658/m31230f1.htm#2498114 Filing: 000121465923003658 The citation records this snapshot. The page link may show a newer release later.	−GBP 6.8 million Calculation and evidence -6489000 − 310000 GBP Exact free cash flow: -6799000 GBP 2019-01-01 – 2019-12-31: -6489000 GBP · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 310000 GBP · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Midatech Pharma Plc · 2019-12-31 Midatech Pharma Plc (edgar:1643918) Free cash flow: -6799000 GBP Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6489000 GBP (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465923003658/m31230f1.htm#2489682 Filing: 000121465923003658 Input fundies:CapitalExpenditure: 310000 GBP (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465923003658/m31230f1.htm#2498114 Filing: 000121465923003658 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	Unavailable Not reported for this period.	−GBP 9.3 million Exact value Exact value: -9301000 GBP 2020-01-01 – 2020-12-31: -9301000 GBP Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Midatech Pharma Plc · 2020-12-31 Midatech Pharma Plc (edgar:1643918) Operating Cash Flow: -9301000 GBP Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=GBP&dimensions= Input fundies:OperatingCashFlow: -9301000 GBP (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465924004701/j311241f1.htm#2626949 Filing: 000121465924004701 The citation records this snapshot. The page link may show a newer release later.	GBP 209,000 Exact value Exact value: 209000 GBP 2020-01-01 – 2020-12-31: 209000 GBP Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Midatech Pharma Plc · 2020-12-31 Midatech Pharma Plc (edgar:1643918) Capital Expenditure: 209000 GBP Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=GBP&dimensions= Input fundies:CapitalExpenditure: 209000 GBP (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465924004701/j311241f1.htm#2632888 Filing: 000121465924004701 The citation records this snapshot. The page link may show a newer release later.	−GBP 9.51 million Calculation and evidence -9301000 − 209000 GBP Exact free cash flow: -9510000 GBP 2020-01-01 – 2020-12-31: -9301000 GBP · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 209000 GBP · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Midatech Pharma Plc · 2020-12-31 Midatech Pharma Plc (edgar:1643918) Free cash flow: -9510000 GBP Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9301000 GBP (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465924004701/j311241f1.htm#2626949 Filing: 000121465924004701 Input fundies:CapitalExpenditure: 209000 GBP (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465924004701/j311241f1.htm#2632888 Filing: 000121465924004701 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−GBP 5.46 million Exact value Exact value: -5460000 GBP 2021-01-01 – 2021-12-31: -5460000 GBP Inspect Net Income Open source Share or cite Citation for Net Income · Midatech Pharma Plc · 2021-12-31 Midatech Pharma Plc (edgar:1643918) Net Income: -5460000 GBP Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=GBP&dimensions= Input fundies:NetIncome: -5460000 GBP (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/i114255f1.htm#2882720 Filing: 000121465925000922 The citation records this snapshot. The page link may show a newer release later.	−GBP 6.01 million Exact value Exact value: -6008000 GBP 2021-01-01 – 2021-12-31: -6008000 GBP Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Midatech Pharma Plc · 2021-12-31 Midatech Pharma Plc (edgar:1643918) Operating Cash Flow: -6008000 GBP Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=GBP&dimensions= Input fundies:OperatingCashFlow: -6008000 GBP (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/i114255f1.htm#3004054 Filing: 000121465925000922 The citation records this snapshot. The page link may show a newer release later.	GBP 320,000 Exact value Exact value: 320000 GBP 2021-01-01 – 2021-12-31: 320000 GBP Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Midatech Pharma Plc · 2021-12-31 Midatech Pharma Plc (edgar:1643918) Capital Expenditure: 320000 GBP Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=GBP&dimensions= Input fundies:CapitalExpenditure: 320000 GBP (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/i114255f1.htm#3011660 Filing: 000121465925000922 The citation records this snapshot. The page link may show a newer release later.	−GBP 6.33 million Calculation and evidence -6008000 − 320000 GBP Exact free cash flow: -6328000 GBP 2021-01-01 – 2021-12-31: -6008000 GBP · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 320000 GBP · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Midatech Pharma Plc · 2021-12-31 Midatech Pharma Plc (edgar:1643918) Free cash flow: -6328000 GBP Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6008000 GBP (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/i114255f1.htm#3004054 Filing: 000121465925000922 Input fundies:CapitalExpenditure: 320000 GBP (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/i114255f1.htm#3011660 Filing: 000121465925000922 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−GBP 7.66 million Exact value Exact value: -7656000 GBP 2022-01-01 – 2022-12-31: -7656000 GBP Inspect Net Income Open source Share or cite Citation for Net Income · Midatech Pharma Plc · 2022-12-31 Midatech Pharma Plc (edgar:1643918) Net Income: -7656000 GBP Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=GBP&dimensions= Input fundies:NetIncome: -7656000 GBP (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/i114255f1.htm#2882275 Filing: 000121465925000922 The citation records this snapshot. The page link may show a newer release later.	−GBP 7.05 million Exact value Exact value: -7048000 GBP 2022-01-01 – 2022-12-31: -7048000 GBP Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Midatech Pharma Plc · 2022-12-31 Midatech Pharma Plc (edgar:1643918) Operating Cash Flow: -7048000 GBP Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=GBP&dimensions= Input fundies:OperatingCashFlow: -7048000 GBP (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/bp4225120f.htm#1933074 Filing: 000121465925005742 The citation records this snapshot. The page link may show a newer release later.	GBP 62,000 Exact value Exact value: 62000 GBP 2022-01-01 – 2022-12-31: 62000 GBP Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Midatech Pharma Plc · 2022-12-31 Midatech Pharma Plc (edgar:1643918) Capital Expenditure: 62000 GBP Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=GBP&dimensions= Input fundies:CapitalExpenditure: 62000 GBP (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/bp4225120f.htm#1939977 Filing: 000121465925005742 The citation records this snapshot. The page link may show a newer release later.	−GBP 7.11 million Calculation and evidence -7048000 − 62000 GBP Exact free cash flow: -7110000 GBP 2022-01-01 – 2022-12-31: -7048000 GBP · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 62000 GBP · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Midatech Pharma Plc · 2022-12-31 Midatech Pharma Plc (edgar:1643918) Free cash flow: -7110000 GBP Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7048000 GBP (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/bp4225120f.htm#1933074 Filing: 000121465925005742 Input fundies:CapitalExpenditure: 62000 GBP (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925005742/bp4225120f.htm#1939977 Filing: 000121465925005742 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−GBP 7.08 million Exact value Exact value: -7079000 GBP 2023-01-01 – 2023-12-31: -7079000 GBP Inspect Net Income Open source Share or cite Citation for Net Income · Midatech Pharma Plc · 2023-12-31 Midatech Pharma Plc (edgar:1643918) Net Income: -7079000 GBP Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=GBP&dimensions= Input fundies:NetIncome: -7079000 GBP (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465925000922/i114255f1.htm#2881830 Filing: 000121465925000922 The citation records this snapshot. The page link may show a newer release later.	−GBP 6.83 million Exact value Exact value: -6826000 GBP 2023-01-01 – 2023-12-31: -6826000 GBP Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Midatech Pharma Plc · 2023-12-31 Midatech Pharma Plc (edgar:1643918) Operating Cash Flow: -6826000 GBP Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=GBP&dimensions= Input fundies:OperatingCashFlow: -6826000 GBP (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1948120 Filing: 000121465926003921 The citation records this snapshot. The page link may show a newer release later.	GBP 26,000 Exact value Exact value: 26000 GBP 2023-01-01 – 2023-12-31: 26000 GBP Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Midatech Pharma Plc · 2023-12-31 Midatech Pharma Plc (edgar:1643918) Capital Expenditure: 26000 GBP Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=GBP&dimensions= Input fundies:CapitalExpenditure: 26000 GBP (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1954443 Filing: 000121465926003921 The citation records this snapshot. The page link may show a newer release later.	−GBP 6.85 million Calculation and evidence -6826000 − 26000 GBP Exact free cash flow: -6852000 GBP 2023-01-01 – 2023-12-31: -6826000 GBP · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 26000 GBP · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Midatech Pharma Plc · 2023-12-31 Midatech Pharma Plc (edgar:1643918) Free cash flow: -6852000 GBP Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6826000 GBP (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1948120 Filing: 000121465926003921 Input fundies:CapitalExpenditure: 26000 GBP (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1954443 Filing: 000121465926003921 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	Unavailable Not reported for this period.	−GBP 12.26 million Exact value Exact value: -12261000 GBP 2024-01-01 – 2024-12-31: -12261000 GBP Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Midatech Pharma Plc · 2024-12-31 Midatech Pharma Plc (edgar:1643918) Operating Cash Flow: -12261000 GBP Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=GBP&dimensions= Input fundies:OperatingCashFlow: -12261000 GBP (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1947491 Filing: 000121465926003921 The citation records this snapshot. The page link may show a newer release later.	GBP 9,000 Exact value Exact value: 9000 GBP 2024-01-01 – 2024-12-31: 9000 GBP Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Midatech Pharma Plc · 2024-12-31 Midatech Pharma Plc (edgar:1643918) Capital Expenditure: 9000 GBP Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=GBP&dimensions= Input fundies:CapitalExpenditure: 9000 GBP (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1953959 Filing: 000121465926003921 The citation records this snapshot. The page link may show a newer release later.	−GBP 12.27 million Calculation and evidence -12261000 − 9000 GBP Exact free cash flow: -12270000 GBP 2024-01-01 – 2024-12-31: -12261000 GBP · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 9000 GBP · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Midatech Pharma Plc · 2024-12-31 Midatech Pharma Plc (edgar:1643918) Free cash flow: -12270000 GBP Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12261000 GBP (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1947491 Filing: 000121465926003921 Input fundies:CapitalExpenditure: 9000 GBP (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1953959 Filing: 000121465926003921 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	Unavailable Not reported for this period.	−GBP 5.59 million Exact value Exact value: -5591000 GBP 2025-01-01 – 2025-12-31: -5591000 GBP Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Midatech Pharma Plc · 2025-12-31 Midatech Pharma Plc (edgar:1643918) Operating Cash Flow: -5591000 GBP Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=GBP&dimensions= Input fundies:OperatingCashFlow: -5591000 GBP (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1946861 Filing: 000121465926003921 The citation records this snapshot. The page link may show a newer release later.	GBP 2,000 Exact value Exact value: 2000 GBP 2025-01-01 – 2025-12-31: 2000 GBP Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Midatech Pharma Plc · 2025-12-31 Midatech Pharma Plc (edgar:1643918) Capital Expenditure: 2000 GBP Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=GBP&dimensions= Input fundies:CapitalExpenditure: 2000 GBP (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1953473 Filing: 000121465926003921 The citation records this snapshot. The page link may show a newer release later.	−GBP 5.59 million Calculation and evidence -5591000 − 2000 GBP Exact free cash flow: -5593000 GBP 2025-01-01 – 2025-12-31: -5591000 GBP · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 2000 GBP · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Midatech Pharma Plc · 2025-12-31 Midatech Pharma Plc (edgar:1643918) Free cash flow: -5593000 GBP Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:20:42Z Snapshot: 05acc199b29c2f11ebdd2d17249e97c29e02d7f1933425016f1b96ca47c6b254 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1643918?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5591000 GBP (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1946861 Filing: 000121465926003921 Input fundies:CapitalExpenditure: 2000 GBP (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1643918/000121465926003921/bp31726520f.htm#1953473 Filing: 000121465926003921 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

293 filings · 895 latest values · 895 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001643918, 1643918, BDRX, MTP, MTPH, edgar:1643918

Also known as BIODEXA PHARMACEUTICALS PLC, Biodexa Pharmaceuticals PLC, Biodexa Pharmaceuticals Plc, Biodexa Pharmaceuticals plc, Midatech Pharma Plc, Midatech Pharma plc

Midatech Pharma Plc

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation